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Abstract
Objective—Melanoma incidence and mortality are increasing among United States (U.S.) adults. 
Currently, routine skin cancer screening total body skin examinations (TBSEs) by a physician are 
not recommended by the United States Preventive Services Task Force (USPSTF); while 
organizations such as the American Cancer Society recommend screening. Currently, there are 
limited data on the prevalence, correlates, and trends of TBSE among U.S. adults.
Methods—We analyzed data by race/ethnicity, age, and skin cancer risk level, among other 
characteristics from three different National Health Interview Survey (NHIS) cancer control 
supplements conducted every five years since 2000 in random U.S. households. High-risk status 
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and middle-risk status were defined based on the USPSTF criteria (age, race, sunburn, and family 
history).
Results—Prevalence of having at least one TBSE increased from 14.5 in 2000 to 16.5 in 2005 to 
19.8 in 2010 (P = 0.0001). In 2010, screening rates were higher among the elderly, the fair-
skinned, those reporting sunburn(s), and individuals with a family history of skin cancer. 
Approximately 104.7 million (51.1%) U.S. adults are at high-risk for developing melanoma, of 
which 24.0% had at least one TBSE.
Conclusions—TBSE rates have been increasing since 2000 both overall and among higher-risk 
groups. Data on screening trends could help tailor future prevention strategies.
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Introduction
Skin cancer is the most common cancer in the United States. In 2010, there were an 
estimated two million cases of non-melanoma skin cancer with less than 1000 deaths (NCI, 
2013); while, in 2009, there were over 61,646 melanoma cases and 9199 deaths due to 
melanoma (USCS, 2013). Melanoma is one of the few cancers that has been increasing in 
both incidence and mortality in the U.S. (Rogers et al., 2010). During the past three decades, 
the melanoma rates have increased nearly three-fold, from 7.9 per 100,000 in 1975 to 23.1 
per 100,000 in 2009. Mortality from melanoma has increased by 33%, from 2.1 per 100,000 
in 1975 to 2.8 per 100,000 in 2009 (Howlader et al.). Annual direct costs of treatment for 
melanoma were estimated to be $44.9 million for Medicare recipients with previously 
diagnosed cancers and $932.5 million for all Americans with newly diagnosed cases (Guy et 
al., 2012).
Although there are limited data on the mortality benefit of population-based TBSE 
screening, studies have found that periodic total body skin examinations (TBSEs) conducted 
by physicians may increase the likelihood of detecting melanomas at relatively earlier 
stages, thereby potentially increasing survival time and quality of life and decreasing costs 
of treatment (Goldberg et al., 2007; Guy et al., 2012). The United States Preventive Services 
Task Force (USPSTF) (2009) found insufficient evidence to assess the balance of benefits 
and harms of total body skin examination by a clinician or patient skin self-examination for 
the early detection of skin cancer in the general U.S. adult population and even among high-
risk groups (USPSTF, 2001; Wolff et al., 2009). The American Cancer Society's (ACS) 
evidence- and consensus-based recommendation for 2013 is that individuals aged ≥20 years 
should undergo routine screening for skin cancer during their periodic health visit. The 
American Academy of Dermatology recommends annual screening TBSEs, and also 
advocates skin self-examination through campaigns such as “Melanoma Monday” (AAD, 
2012) (see Appendix 1 for more skin cancer screening guidelines.) The ACS and the 
American College of Obstetricians and Gynecologists support skin cancer screening of high-
risk individuals (ACOG, 2012; ACS, 2013) The USPSTF defines high-risk groups for 
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melanoma as follows: fair-skinned men and women aged >65 years, as well as those who: 
report sunburn(s), have a family history of skin cancer, and have >50 or atypical moles.
Lack of agreement among major U.S. medical organizations regarding the use of TBSE for 
skin cancer screening may impact screening practices within the U.S. population (AAD, 
2012; ACS, 2013; Koh et al., 1996; USPSTF, 2012; Wolff et al., 2009). One study using the 
2005 National Health Interview Survey (NHIS) data found that skin cancer screening rates 
were considerably lower (17%) than the screening rates for breast (54%) and colorectal 
(51%) cancers, where routine screening is generally recommended (Coups et al., 2010).
At present, there are limited data on TBSE prevalence and trends over time, and 
characteristics of those screened compared to those not screened in the general U.S. adult 
population as well as high-risk adult groups. Our study utilizes nationally representative data 
from the NHIS to add to the research in those areas.
Methods
Our data source, the NHIS, is an annual, cross-sectional, household interview survey of the 
civilian, non-institutionalized U.S. adult population, which has been conducted by the 
Centers for Disease Control and Prevention's National Center for Health Statistics (CDC/
NCHS) since 1960. NHIS is a public-use dataset that does not include identifiable data; thus, 
our analysis is exempt from IRB review. Each year, members of approximately 35,000 
households participate in the NHIS. In 2000, 2005, and 2010, the NHIS included a cancer 
control supplement, in which survey respondents were asked, “Have you ever had all of 
your skin from head to toe checked for cancer either by a dermatologist or some other kind 
of doctor?” Those who replied that they had were then asked follow-up questions regarding 
the timing of their most recent TBSE. The supplement was administered to one randomly 
selected adult per household. The survey samples, which refer to the total number of sample 
adults, consisted of 32,374 respondents in 2000, 31,428 in 2005, and 27,157 in 2010. 
Response rates were 72.1% in 2000, 69.0% in 2005, and 60.8% in 2010. We excluded 
respondents with a history of any type of skin cancer (2000: n = 700; 2005: n = 750; 2010: n 
= 753) from our main analysis because their TBSEs may have been performed to monitor 
the progress of a previously diagnosed cancer rather than to detect a previously undiagnosed 
cancer. In our analyses, we estimated the percentage of U.S. adults who had ever obtained a 
TBSE, both overall and by age, sex, and race/ethnicity (a proxy for level of pigmentation). 
Percentages were age-standardized to the 2000 U.S. standard million population (Klein and 
Schoenborn, 2001). Ninety-five percent confidence intervals around the percentages were 
calculated based on a logit transformation. Statistical testing for differences in age-
standardized percentages was performed using general linear contrasts. Year was treated as a 
categorical variable in order to test for any differences over time rather than assuming a 
linear trend. A multivariable logistic regression model was used to calculate adjusted TBSE 
percentages as predictive margins. The predictive margin for a specific group represents the 
average predicted response if everyone in the sample had been in that group. An additional 
multivariable logistic regression model was fit to assess trends in TBSE over time. Race 
(Hispanic White, non-Hispanic White, non-White) by year interaction terms were included 
to determine if the year effect varied by race. Skin reaction to sunlight (both short- and long-
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term exposure) and selected family history (any skin cancer and any cancer) variables were 
excluded from the models to avoid collinearity with protective behaviors and family history 
of melanoma/ non-melanoma skin cancer, respectively. TBSE patterns over the past 10 
years were also analyzed among the high-risk individuals aged >65 years, those who 
reported 1 or more sunburn(s), and those with a family history of skin cancer. Statistical 
testing for the age-adjusted and multivariable analyses was based on the Wald F test. SAS 
version 9.2 and SUDAAN version 10.0.1 were used to account for the complex sampling 
design and to allow for weighting of the estimates.
Using USPSTF guidelines, we defined the following groups as being at high-risk for skin 
cancer: non-Hispanic White men and women aged >65 years, respondents who reported 
having been sunburned, and respondents with a family history of skin cancer. High risk 
characteristics such as many moles (>50) or atypical moles could not be ascertained as they 
were not asked on the NHIS. Medium-risk individuals were defined as non-Hispanic White 
individuals aged ≤65 years who did not meet the high-risk criteria. Low-risk individuals 
were the remaining group of U.S. adults. Numbers of high-, medium-, and low-risk U.S. 
adults were calculated using NHIS population total estimates. The numbers of individuals 
screened were calculated by multiplying the NHIS screening percentage times the U.S. adult 
population estimate for each high-, medium-, and low-risk group (and the high-risk sub-
groups). We looked to assess this risk classification by examining the distribution in those 
respondents that were excluded due to a history of skin cancer. For all three years combined, 
76.0% of those with a skin cancer history were considered high-risk with 22.1% medium-
risk and only 1.8% low-risk.
Results
Reports of ever having had a TBSE increased nationally from 14.5% [95% CI (14.0–15.0)] 
in 2000 to 16.5% [95% CI (14.0–15.0)] in 2005 to 19.8% [95% CI (19.1–20.5)] in 2010 (P < 
0.0001). Between 2000, 2005, and 2010, there were significant increases in screening among 
all age groups, with the most screenings being reported among non-Hispanic Whites and 
individuals age 50 and above (all P < 0.05). TBSE rates increased each year among both 
men and women. In 2010, the percentage of adults who had ever had a TBSE was positively 
associated (P < 0.0001) with having more education, doing more physical activity, having 
had a severe skin reaction to sunlight after 1 h or longer exposure, using sun protection (e.g., 
wearing a long-sleeved shirt, wearing a wide-brimmed hat, or using sunscreen with an SPF 
rating of 15 or greater), and going to a tanning salon in the past year (Table 1).
There was a significant race by year interaction in the adjusted model predicting ever having 
a TBSE (P < 0.0001) (Table 2). A significant increase in ever having a TBSE was found 
among non-Hispanic Whites between 2000 and 2010 (adjusted odds ratio [OR] for 2010 vs. 
2000 = 1.66 [95% CI: 1.55–1.79]). In 2010, the odds of ever having a TBSE among non-
Hispanic Whites were about 2.5 times those of Hispanic Whites and non-Whites.
Our estimates also show that at least half of the U.S. adult population, or approximately 
104.7 million adults would be considered high-risk for skin cancer based on the USPSTF 
criteria. Among the selected high-risk individuals, 24.0% or about 25.3 million adults had a 
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TBSE once in their lifetime, and 11.3% or about 12.0 million adults had a TBSE in the past 
year. Among the medium-risk group, 24.2% or about 11.9 million adults had a TBSE once 
in their lifetime, and 9.5% or approximately 4.7 million adults had a TBSE in the past year 
(Table 3).
Discussion
Between 2000 and 2010, there was a significant increase in ever having a TBSE among U.S. 
adults nationally from 1 in 7 (2000) to 1 in 6 (2005) to 1 in 5 (2010) U.S. adults (P < 
0.0001) (Fig. 1A). However, rates of ever having a TBSE either did not increase or remained 
stable in 2005 and 2010 compared to 2000 among Blacks, Asians, and AI/AN (Fig. 1B). 
Lifetime TBSE rates in 2010 were higher among three groups of U.S. adults at high-risk for 
skin cancer, specifically, fair-skinned men and women aged >65 years, adults reporting 
more sunburns, and individuals with a family history of skin cancer. Yet, three out of four 
high-risk individuals, who may be most likely to develop skin cancer, never had a TBSE 
(Table 3). Among high-risk groups, those with a family history of skin cancer followed by 
White, non-Hispanics >65 years were most likely to report and individuals reporting ≥2 
sunburns were least likely to report ever having a TBSE.
At present, the USPSTF states that it is unclear whether benefits of routine TBSEs outweigh 
harms and also whether screening is beneficial for high-risk populations (USPSTF, 2001; 
Wolff et al., 2009). Potential harms of TBSE screening include: overdiagnosis via the 
detection of biologically benign disease that would otherwise go undetected, misdiagnosis of 
a benign lesion as malignant, complications of diagnostic or treatment interventions 
(including surgery), the psychological effects of being labeled with a potentially fatal 
disease, and the discomfort of a bare skin total body exam.
However, in 2012, the USPSTF did recommend that primary care physicians should counsel 
their fair-skinned patients aged 10–24 years on sun-protective behaviors and decreasing 
indoor tanning (USPSTF, 2012). Enhancing primary prevention strategies, such as targeted 
education, may be important during this period of uncertainty on screening guidelines 
(Andreeva and Cockburn, 2011).
The strengths of this study are related to its use of NHIS, which has a high response rate, 
sample diversity, the ability to provide estimates that are nationally representative, a large 
sample size, and experienced survey administrators. Limitations of this study include: self-
reported responses that were subject to recall bias, responses that were not verified with 
medical records, use of a cancer module that is conducted every five years, and challenges 
with population estimates. Additionally, since this is a cross-sectional analysis, causal 
relationships cannot be determined.
Conclusions
Our study results show that TBSE rates have been increasing since 2000 both overall and 
among high-risk groups in spite of years of inconclusive and inconsistent evidence on 
routine screening via TBSEs and as a result less public education on skin cancer prevention 
and screening. Despite the increases, the incidence and mortality of melanoma have been 
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rising during that timeframe. The increase in incidence may be due to increased diagnosis of 
melanomas as a result of more screening, however, this phenomenon does not explain the 
rise in mortality and warrants further investigation. Analyzing patterns among those who 
have received TBSEs highlights groups who have lower TBSE rates and who may benefit 
most from skin cancer prevention education. Among high-risk groups, these included 
individuals reporting one or more sun-burn(s). Additionally, fair-skinned young adults, those 
with no health insurance, and those reporting not having a primary care physician may also 
need to be targeted as at-risk groups since they reported relatively lower TBSE usage in 
2010 compared to their opposing counterparts (Table 1). Gaps in current skin cancer 
screening research include: demonstrating a mortality benefit, identifying populations that 
would benefit from routine screening, understanding which screening methods should be 
promoted, and calculating the financial and social impact of skin cancer. In this current 
setting, data from our study may help plan future skin cancer prevention strategies, 
especially among high-risk and at-risk groups.
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Appendix 1. Skin cancer screening and counseling guidelines
U.S. Preventive Services 
Task Force (USPSTF) 
(USPSTF, 2012; Wolff et 
al., 2009)
American Cancer 
Society (ACS) 
(ACS, 2013)
American Academy of 
Dermatology (AAD) 
(AAD, 2013; Koh et al., 
1996)
2009, 2012 2013 Since 1985
When to start screening Not addressed. Adults aged ≥20 
years during a 
periodic health 
check-up.
Not addressed.
Screening method & intervals Not addressed Not addressed Not addressed
Patient skin self-examination Insufficient evidence. (I 
statement)
Not addressed. Recommended annually.
Total-body skin examination 
(TBSE) performed by a 
physician
Insufficient evidence. (I 
statement)
Not addressed. Program endorses TBSE by 
a dermatologist for the 
general population.
High risk (not average risk) Clinicians should be aware 
that fair-skinned men and 
women >65 years, patients 
with atypical moles, and 
those with >50 moles 
constitute known groups at 
substantially increased risk 
for melanoma. Other risk 
factors for skin cancer 
include: family history of 
skin cancer and a past history 
of considerable sun exposure 
and sunburns. Benefits from 
Not addressed. Not addressed.
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U.S. Preventive Services 
Task Force (USPSTF) 
(USPSTF, 2012; Wolff et 
al., 2009)
American Cancer 
Society (ACS) 
(ACS, 2013)
American Academy of 
Dermatology (AAD) 
(AAD, 2013; Koh et al., 
1996)
2009, 2012 2013 Since 1985
screening are uncertain, even 
in high-risk patients.
Behavioral counseling Children, adolescents, and 
young adults aged 10 to 24 
years who have fair skin, 
should be counseled on 
minimizing their exposure to 
ultraviolet radiation to reduce 
risk for skin cancer (B 
statement). For adults ≥25 
years, insufficient evidence. 
(I statement)
At a periodic 
health checkup, 
adults ≥20 years 
should receive 
examination of the 
skin and health 
counseling about 
sun exposure.
Recommended.
When to stop screening Not addressed. Not addressed. Not addressed.
Family history tool for patient 
self-assessment
My Family Health Portrait, a 
tool by the Surgeon General.
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Fig. 1. 
A: Weighted percentage of U.S. adults who reported ever having a total body skin 
examination (TBSE) to screen for skin cancer overall and by age, and year, National Health 
Interview Survey (NHIS) 2000, 2005, and 2010. B: Weighted percentage of U.S. adults who 
reported ever having a total body skin examination (TBSE) to screen for skin cancer by 
gender, and race/ethnicity, and year, National Health Interview Survey (NHIS) 2000, 2005, 
and 2010.
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Table 1
Percentage of U.S. adults who ever had a total body skin examination, overall and by selected characteristics, 
NHIS 2010.
Characteristic: N Age-Std %a (95% CI)* Predictive marginsb % (95% CI)**
Total 24,421 19.8 (19.1–20.5) 20.1 (19.3–20.8)
Age (years) 24,421 P < 0.0001 P < 0.0001
 18–29 4947 9.1 (8.2–10.2) 12.1 (10.7–13.6)
 30–39 4527 14.2 (12.9–15.5) 15.3 (13.9–16.7)
 40–49 4399 20.4 (19.0–22.0) 20.2 (18.8–21.8)
 50–64 5938 27.2 (25.7–28.7) 24.5 (23.1–25.9)
 65–74 2467 30.2 (28.0–32.5) 26.1 (23.8–28.5)
 ≥75 2143 31.2 (28.6–33.9) 27.9 (24.7–31.3)
Sex 24,421 P = 0.0005 P = 0.4346
 Male 10,743 18.7 (17.9–19.7) 20.3 (19.3–21.4)
 Female 13,678 20.9 (20.0–21.8) 19.8 (18.9–20.8)
Race/ethnicity 24,421 P < 0.0001 P < 0.0001
 White, Hispanic 4348 8.3 (7.3–9.5) 13.6 (11.5–16.1)
 White, non-Hispanic 13,803 24.4 (23.6–25.3) 22.4 (21.5–23.3)
 Black 4263 10.2 (9.2–11.4) 13.2 (11.7–14.9)
 Asian/Pacific Islander 1644 8.7 (7.2–10.6) 9.9 (8.1–12.0)
 American Indian/Alaska Native 241 11.4 (7.3–17.5) 14.6 (9.2–22.3)
 Other/multiracial 122 6.3 (3.3–11.7) 16.7 (9.1–28.8)
Region 24,421 P < 0.0001 P < 0.0001
 South 8949 19.3 (18.3–20.5) 20.9 (19.8–22.0)
 Midwest 5369 18.3 (16.9–19.7) 17.5 (16.2–18.7)
 Northeast 3883 25.2 (23.5–26.9) 24.6 (23.1–26.2)
 West 6220 18.0 (16.9–19.2) 18.2 (17.1–19.3)
Education 24,326 P < 0.0001 P < 0.0001
 <HS 4209 8.0 (7.1–9.0) 12.7 (11.2–14.4)
 HS grad/GED 6423 14.5 (13.5–15.6) 16.3 (15.2–17.4)
 Some college/tech school 7291 21.1 (20.0–22.2) 20.5 (19.3–21.7)
 College graduate 6403 29.4 (28.0–30.8) 25.1 (23.8–26.5)
Usual place of health care 24,417 P < 0.0001 P = 0.0358
 No 4550 10.2 (8.9–11.8) 17.9 (16.0–19.9)
 Yes 19,867 21.4 (20.6–22.1) 20.3 (19.5–21.1)
Health care coverage 24,353 P < 0.0001 P = 0.0001
 No 4698 8.4 (6.5–10.9) 15.9 (13.9–18.2)
 Yes 19,655 21.9 (21.1–22.7) 20.5 (19.8–21.3)
Physical activityc 23,954 P < 0.0001 P < 0.0001
 No activity 8597 12.6 (11.7–13.5) 16.0 (15.0–17.1)
 Some activity 5308 19.4 (18.1–20.8) 19.3 (18.0–20.7)
 Meets/exceeds recommendations 10,049 25.7 (24.7–26.8) 22.9 (22.0–24.0)
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Characteristic: N Age-Std %a (95% CI)* Predictive marginsb % (95% CI)**
Sun protectiond 24,011 P < 0.0001 P < 0.0001
 Do not go out in sun 1163 11.9 (9.7–14.6) 19.6 (17.0–22.4)
 Sometimes/rarely/never 13,092 15.1 (14.3–15.9) 16.7 (15.9–17.7)
 Always/most of the time 9756 26.8 (25.7–27.9) 23.8 (22.7–24.8)
Use of tanning salon in past year 24,376 P = 0.0025 P = 0.0360
 No 23,218 19.4 (18.7–20.1) 19.9 (19.1–20.6)
 Yes 1158 26.6 (22.3–31.4) 23.1 (20.2–26.2)
Sunburns in past year 24,307 P < 0.0001 P = 0.2653
 0 16,318 17.8 (17.0–18.6) 20.5 (19.6–21.4)
 1–2 6262 23.1 (21.7–24.6) 19.6 (18.6–20.7)
 3 or more 1727 23.6 (20.9–26.4) 18.8 (16.8–21.1)
Personal history of any cancer 24,421 P < 0.0001 P < 0.0001
 No 22,988 18.9 (18.3–19.6) 19.3 (18.6–20.1)
 Yes 1433 34.8 (30.2–39.7) 29.8 (27.2–32.6)
Family history of skin cancer (non-melanoma) 23,802 P < 0.0001 P = 0.0010
 No 23,333 19.5 (18.8–20.1) 19.9 (19.2–20.6)
 Yes 469 35.2 (30.1–40.8) 25.9 (22.2–30.0)
Family history of melanoma 23,802 P < 0.0001 P < 0.0001
 No 23,357 19.4 (18.8–20.1) 19.8 (19.1–20.5)
 Yes 445 39.2 (33.4–45.2) 30.7 (26.5–35.2)
Characteristics excluded from model due to issues with collinearity or singularity:
Skin reaction, 1 he 23,724 P < 0.0001
 Do not go out in sun 1698 13.9 (11.5–16.7)
 No sunburn, tanning, nothing 10,623 14.6 (13.7–15.5)
 Mild sunburn, some tanning 5291 23.8 (22.5–25.1)
 Severe sunburn 6112 25.2 (24.0–26.4)
Skin reaction, long exposuree 23,349 P < 0.0001
 Do not go out in sun 2168 6.0 (4.9–7.4)
 Very dark tan 3213 8.0 (6.9–9.4)
 Moderate tan 7592 8.9 (8.2–9.7)
 Mild tan 7223 8.3 (7.5–9.2)
 Repeated sunburns/freckled 3123 12.3 (11.1–13.7)
N = unweighted sample size; model N = 22,018 with 4099 events.
CI = confidence interval; Std = Standardized.
*
For age standardized %: P-value for global test of association calculated using Wald F test.
**
For predictive margins %: P-value based on the Wald F test statistic for the simultaneous test that all beta coefficients associated with a given 
variable are equal to 0.
a
Percentages are age-standardized to the 2000 U.S. standard population according to the following age groups: 18–29, 30–34, 35–39, 40–44, 45–
49, 50–54, 55–59, 60–64, 65–69, and ≥70.
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b
Predictive margins calculated from multivariable logistic regression model including all covariates in Table 2 except where noted. In addition, the 
following variables not included in the table were also adjusted for: employment status, primary language spoken, marital status, cigarette smoking, 
excessive alcohol use, physician seen in past year, self-reported health status, routine consumption of multivitamins, and body mass index.
c
The following formula was used to calculate metabolic equivalent (MET) minutes per week from the number of minutes per week of moderate 
and vigorous exercise: 4.5 × moderate minutes per week + 7.0 × vigorous minutes per week. Physical activity was defined as no activity (MET 
minutes per week = 0), some activity (MET minutes per week = 1–<675), or meets/exceeds recommendations (MET minutes per week ≥ 675) 
(Ainsworth BE and 2000).
d
Defined as wearing a long-sleeved shirt, wearing a wide-brimmed hat, or using sunscreen with an SPF rating of 15 or greater.
eCharacteristic excluded from model due to issues with collinearity or singularity.
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Table 2
Adjusteda associations of year and race on ever having a total body skin examination among U.S. adults; 
NHIS 2000, 2005, and 2010.
Raceb Odds ratio (95% CI)
2000
 White non-Hispanic vs. White Hispanic 1.71 (1.37–2.15)
 White non-Hispanic vs. non-White 1.26 (1.10–1.44)
2005
 White non-Hispanic vs. White Hispanic 1.82 (1.55–2.15)
 White non-Hispanic vs. non-White 1.68 (1.46–1.94)
2010
 White non-Hispanic vs. White Hispanic 2.49 (2.10–2.95)
 White non-Hispanic vs. non-White 2.43 (2.14–2.77)
Year†
 White Hispanic
  2005 vs. 2000 1.18 (0.91–1.53)
  2010 vs. 2000 1.15 (0.88–1.49)
 White non-Hispanic
  2005 vs. 2000 1.25 (1.17–1.35)
  2010 vs. 2000 1.66 (1.55–1.79)
 Non-White
  2005 vs. 2000 0.94 (0.77–1.14)
  2010 vs. 2000 0.86 (0.72–1.02)
aAdjusted for age, sex, marital status, education, region, BMI, smoking status, excessive alcohol use, health status, physical activity level, number 
of sunburns in past year, family history of melanoma, family history of non-melanoma skin cancer, personal history of cancer, usual source of care, 
seen physician in past year, sun protection, health care coverage, and employment status.
b
There was a significant race/ethnicity by year interaction (P ≤ 0.001). Odds ratios for race/ ethnicity and year are presented within levels of the 
other factor.
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